PeploBio
PeploBio is a UK-based clinical contract research organization (CRO) specializing in advanced testing, immune monitoring, and regulatory services to support pharmaceutical and biotech companies. They focus on innovative solutions such as their proprietary MicroCLOT assay for microclot detection, supporting research and clinical trials in chronic diseases, post-viral syndromes, and inflammatory conditions. Their mission is to harness science and innovation to improve global health, with a vision to provide tailored, integrated solutions across regulatory affairs, diagnostics, and clinical research.
Industries
Nr. of Employees
small (1-50)
PeploBio
Guildford, Surrey, United Kingdom, Europe
Services
Analytical testing service to detect and quantify fibrin(ogen) amyloid microclots in fresh or frozen blood/plasma for use in clinical research and trials, with outputs suitable for stratification and PD/MOA analyses.
Custom assay design, optimisation and formal validation for RUO, LDT, IVD and companion diagnostics, including method characterisation, pre-study cut point analysis and regulatory-aligned validation packages.
End-to-end clinical trial testing support including dedicated project management, study feasibility, kit customisation, biospecimen management, sample processing, biomarker analysis and data management.
Multiplex and single-plex immunoassays, cytokine/chemokine panels, ADA testing, IgG quantitation, exosome analysis and circulating tumour cell analysis across multiple sample types.
Molecular testing including qPCR, targeted sequencing, Sanger sequencing, targeted gene expression analysis and gene-editing support for research and development projects.
Sourcing of clinical biospecimens via a global network of collection sites and biobanks, custom collection kit design, temperature-controlled shipping and sample tracking.
Analytical testing service to detect and quantify fibrin(ogen) amyloid microclots in fresh or frozen blood/plasma for use in clinical research and trials, with outputs suitable for stratification and PD/MOA analyses.
Custom assay design, optimisation and formal validation for RUO, LDT, IVD and companion diagnostics, including method characterisation, pre-study cut point analysis and regulatory-aligned validation packages.
End-to-end clinical trial testing support including dedicated project management, study feasibility, kit customisation, biospecimen management, sample processing, biomarker analysis and data management.
Multiplex and single-plex immunoassays, cytokine/chemokine panels, ADA testing, IgG quantitation, exosome analysis and circulating tumour cell analysis across multiple sample types.
Molecular testing including qPCR, targeted sequencing, Sanger sequencing, targeted gene expression analysis and gene-editing support for research and development projects.
Sourcing of clinical biospecimens via a global network of collection sites and biobanks, custom collection kit design, temperature-controlled shipping and sample tracking.
Expertise Areas
- Clinical trial management
- Assay development and validation (RUO, LDT, IVD, CDx)
- Immune monitoring and flow cytometry
- Biomarker analysis and immunoassays
Key Technologies
- Flow cytometry
- Enzyme-linked immunosorbent assay (ELISA)
- Quantitative PCR (qPCR)
- Sanger sequencing
News & Updates
PeploBio Launches Proprietary assay for Microclot Detection
Introduction of a new platform for detecting microclots in blood samples, supporting research and clinical applications.
Top Clinical Laboratory Services Company in UK 2022
Recognition of PeploBio as a leading clinical laboratory in the UK.
Ongoing end-to-end IVDR and FDA Clinical Studies
Support and advice on IVDR and FDA clinical studies for in vitro diagnostics.
Providing a complete suite of diagnostic services including molecular, hematology, and biochemical analysis
Expansion of diagnostic services platform to meet diverse client needs.
FDA's Final Rule on Laboratory Developed Tests: A Phased Approach to Compliance
Discussion on the new FDA regulations for laboratory developed tests and their implications.
Navigating EU IVDR Performance Evaluation: A Comprehensive Guide
Guidance on compliance with the EU In Vitro Diagnostic Regulation.
PeploBio Launches Proprietary assay for Microclot Detection
Introduction of a new platform for detecting microclots in blood samples, supporting research and clinical applications.
Top Clinical Laboratory Services Company in UK 2022
Recognition of PeploBio as a leading clinical laboratory in the UK.
Ongoing end-to-end IVDR and FDA Clinical Studies
Support and advice on IVDR and FDA clinical studies for in vitro diagnostics.
Providing a complete suite of diagnostic services including molecular, hematology, and biochemical analysis
Expansion of diagnostic services platform to meet diverse client needs.
FDA's Final Rule on Laboratory Developed Tests: A Phased Approach to Compliance
Discussion on the new FDA regulations for laboratory developed tests and their implications.
Navigating EU IVDR Performance Evaluation: A Comprehensive Guide
Guidance on compliance with the EU In Vitro Diagnostic Regulation.